Katie Propst, MD
Urogynecology and Reconstructive Pelvic Surgery · Cleveland, OHNPI 1609197888
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (37.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Medtronic at 44.0% of the total. 2025 is the largest year on record at $4,753, 7.8 times the $612 reported in 2019.
Across 31 payments — averaging $201.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Intuitive Surgical$2K
- Boston Scientific$541
- Coloplast$326
- Caldera Medical, Inc$310
- Axonics, Inc.$257
- plus $17 from 1 others
What the payments were for
- Consulting fees$2,36538%
- Speaking & faculty fees$2,00032%
- Food & beverage$1,82229%
- Education$581%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 12 | $2,746 |
| Intuitive Surgical | 2 | $2,047 |
| Boston Scientific | 6 | $541 |
| Coloplast | 3 | $326 |
| Caldera Medical, Inc | 5 | $310 |
| Axonics, Inc. | 2 | $257 |
| Hologic Sales And Service, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURO$2,365
- Da Vinci Surgical System$2,000
- ALTIS$268
- Desara$226
- Axonics$196
- GENERAL PELVIC ORGAN PROLAPSE$130
- Bulkamid$118
- SOLYX$105
How this compares
$6,245 in reported general payments places this provider in the 70th percentile of 60 urogynecology and reconstructive pelvic surgery providers in Ohio.
See all urogynecology and reconstructive pelvic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 54 | $43,201 |
| MyrbetriqMirabegron | 59 | $40,547 |
| Estradiol | 107 | $6,924 |
| Methenamine Hippurate | 20 | $1,223 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 34 | $398 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $237 |
| Cephalexin | 12 | $43 |
| Ibuprofen | 11 | $33 |
| Oxycodone Hcl | 13 | $10 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Cleveland
- Emily SlopnickCleveland$37K
- Ly Hoang RobertsCleveland$23K
- Marie ParaisoCleveland$20K
- Omer AnisCleveland$17K
- Chen ShenharCleveland$13K
- Amy ParkCleveland$11K
- Anne SammarcoCleveland$5K
- Amy GeeCleveland$5K
- Shannon WallaceCleveland$5K
- Graham ChapmanCleveland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.